What is he best known for?
The fields of study he is best known for:
- Enzyme
- Biochemistry
- Organic chemistry
His scientific interests lie mostly in Biochemistry, Dendrimer, Galectin, Stereochemistry and Cycloaddition.
Biochemistry is frequently linked to Adhesion in his study.
His Dendrimer research includes themes of Combinatorial chemistry and Mannose.
His work carried out in the field of Galectin brings together such families of science as Chemical probe, Cell and Glycoconjugate.
His work deals with themes such as Surface plasmon resonance, Benzoic acid, Molecule and Cholera toxin, which intersect with Stereochemistry.
His research in Cycloaddition intersects with topics in Selectivity, Microwave irradiation and Nitrogen.
His most cited work include:
- Multivalent glycoconjugates as anti-pathogenic agents (340 citations)
- Maximising multivalency effects in protein–carbohydrate interactions (250 citations)
- Wedgelike Glycodendrimers as Inhibitors of Binding of Mammalian Galectins to Glycoproteins, Lactose Maxiclusters, and Cell Surface Glycoconjugates (181 citations)
What are the main themes of his work throughout his whole career to date?
Roland J. Pieters focuses on Biochemistry, Stereochemistry, Combinatorial chemistry, Galectin and Organic chemistry.
Many of his studies on Biochemistry apply to Adhesion as well.
His study in Stereochemistry is interdisciplinary in nature, drawing from both Lectin, Receptor, Binding site and Divalent.
The various areas that Roland J. Pieters examines in his Combinatorial chemistry study include Covalent bond, Molecule and Protein structure.
Roland J. Pieters combines subjects such as Lactose, Glycoprotein, Chemical probe, Pentapeptide repeat and Peptide library with his study of Galectin.
His studies in Carbohydrate integrate themes in fields like Biophysics and Glycoconjugate.
He most often published in these fields:
- Biochemistry (38.46%)
- Stereochemistry (24.85%)
- Combinatorial chemistry (13.02%)
What were the highlights of his more recent work (between 2017-2021)?
- Biochemistry (38.46%)
- Peptide (10.06%)
- Microbiology (9.47%)
In recent papers he was focusing on the following fields of study:
Roland J. Pieters mainly investigates Biochemistry, Peptide, Microbiology, Enzyme and Transferase.
His Biochemistry study frequently intersects with other fields, such as Cholera toxin.
His Peptide study integrates concerns from other disciplines, such as Combinatorial chemistry and Mass spectrometry.
In the field of Microbiology, his study on Toxin overlaps with subjects such as A protein.
Roland J. Pieters interconnects In vitro and Function in the investigation of issues within Enzyme.
His work in Transferase covers topics such as Moiety which are related to areas like Divalent and Binding site.
Between 2017 and 2021, his most popular works were:
- PhoX: An IMAC-Enrichable Cross-Linking Reagent (35 citations)
- Fluorescent Trimeric Hemagglutinins Reveal Multivalent Receptor Binding Properties (19 citations)
- Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors (15 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Organic chemistry
- Biochemistry
His main research concerns Biochemistry, In vitro, Mass spectrometry, Combinatorial chemistry and Covalent bond.
His Biochemistry study focuses mostly on Small molecule, Hydroxylation, Chaperone, Glucosamine and 1-Deoxynojirimycin.
His research integrates issues of Prebiotic, Biofilm, Food additive, Cell membrane and Enzyme in his study of In vitro.
The concepts of his Mass spectrometry study are interwoven with issues in Metal affinity chromatography, Reagent, Protein structure and Peptide.
His Combinatorial chemistry research is multidisciplinary, incorporating perspectives in Monoisotopic mass, Fragmentation, Molecule and Proteolytic enzymes.
The study incorporates disciplines such as Binding site and Divalent in addition to Moiety.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
